Dr Shaikat Debnath came to AIBN to deepen his technical knowledge but left also with the skills, confidence and connections to build on his career in renewable energy
AIBN alum Dr Feifei Liu is helping guide potential cancer therapies through the complex drug-development pipeline, driven by the hope that one may ultimately change a patient’s life
Leaving academia was the first major pivot for Dr Tom Williams.The Number 8 Bio CEO reflects on how the skills he developed at AIBN have been central to his startup journey
UQ’s Molecular Clamp technology could help improve health outcomes for millions of people by enabling new vaccines against life-threatening respiratory viral infections